Status:
COMPLETED
Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment
Lead Sponsor:
Egyptian Atomic Energy Authority
Conditions:
Psoriasis
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
Using of human amniotic membrane extra-cellular matrix as a topical treatment for improving Psoriasis Area and Severity Index (PASI).
Detailed Description
Human amniotic membrane extra-cellular matrix was purchased from National center for radiation research and technology, Egypt, under commercial name REGE pro gel.
Eligibility Criteria
Inclusion
- patients have psoriasis lesion
Exclusion
- must stop other line of treatment
Key Trial Info
Start Date :
August 4 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2016
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03440541
Start Date
August 4 2015
End Date
April 8 2016
Last Update
June 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amniotic tissue lab
Cairo, Egypt, 29